EGFR Positive Lung Cancer UK· @EgfrUk · X·· 1 天前评分45
正文 · 机器翻译
#ESMO2026 今日在马德里开幕，EGFR+ #lungcancer 的一大焦点是奥希替尼（osimertinib）失效后会发生什么。
🔬 以下是我们正在关注的 5 项研究，涵盖新的靶向联合疗法、抗体-药物偶联物，以及可指导治疗决策的血液检测。
#LCSM
225 浏览 · 11 赞 · 3 转发 · 0 回复
会议摘要
2719RO按 Rapid oral 1: NSCLC, metastatic 对上
FLAURA2: Analysis of on-treatment plasma EGFRm dynamics and associated clinical outcomes in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum–pemetrexed (plat–pem)
https://esmocongress.esmo.orgLBA73按 Rapid oral 1: NSCLC, metastatic 对上
PACE-LUNG: A multicenter, single-arm, phase II clinical trial evaluating the efficacy of additional chemotherapy for patients with EGFRm NSCLC with the continued presence of plasma ctDNA EGFRm at week 3 after start of osimertinib first-line
https://esmocongress.esmo.org来源：EGFR Positive Lung Cancer UK · x.com